Comparison of hormone therapy alone and in combination with chemotherapy of cisplatin and methotrexate in newly diagnosed patients with stage D2 prostatic cancer

Japanese Journal of Urology

Volumn 87, Issue 4, 1996, Pages 789-796

  Komatsu, Hideki ^a   Maesawa, Hiroaki ^a   Tanabe, Nobuaki ^a   Tago, Kiichiro ^a   Ueno, Ak Ira ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

chemotherapy; cisplatin; hormone therapy; methotrexate; Prostatic cancer

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FOSFESTROL; METHOTREXATE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; ORCHIECTOMY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029975321     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.87.789     Document Type: Article

References (20)

1. Stamey, T.A. and McNeal, J.E.: Adenocarcinoma of the prostate, in Campbell's Urology. 6th ed., p. 1159-1221, Saunders Co., Philadelphia, 1992.
2. Slack, N.H. and Murphy, G.P.: A decade of experience with chemotherapy for prostate cancer. Urology, 22, 1-7, 1983.
3. Yagoda, A. and Petrylak, D.: Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer, 71, 1098-1109, 1993.
4. Isaacs, J.T.: The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer. Prostate, 5, 1-17, 1984.
5. Schoonees, R., Schalch, D.S., Reynoso, G. and Murphy, G.P.: Bilateral adrenalectomy for advanced prostatic carcinoma. J. Urol., 108, 123-125, 1972.
6. Silverberg, G.D.: Hypophysectomy in the treatment of disseminated prostate carcinoma. Cancer, 39, 1727-1731, 1977.
7. Loening, S. and Lubaroff, D.: Cryosurgery and immunothetapy for prostatic cancer. Urol. Clin. North Am., 11, 327-336, 1984.
8. Merrin, C. and Beckley, S.: Treatment of estrogen-resistant stage D carcinoma of prostate with cis diamminedichloroplatinum. Urology, 13, 267-272, 1979.
9. Jones, M.A and Williams, G.: The nonhormone chemotherapy of prostatic cancer. Brit J. Urol., 52, 127-130, 1980.
10. Loening, S.A., Beckley, S., Brady, M.F., Chu, T M., deKernion, J.B., Dhabuwala, C., Gaeta, J.F., Gibbons, R.P., McKiel, C.F., McLeod, D.G., Pontes, J.E., Prout, G.R., Scardino, P T., Schlegel, J.U., Schmidt, J.D., Scott, W.W., Slack, N.H., Soloway, M.S and Murphy, G.P.: Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer. J. Urol., 129, 1001-1006, 1983.
11. Kubota, Y., Nakada, T , Imai, K., Yamanaka, H., Sakai, H , Saito, Y., Tomaru, Y., Kitamura, K., Sugano, O. and Sasagawa, I.: Chemoendocrine therapy in patients with stage D2 prostate cancer. The Prostate, 26, 50-54, 1995.
12. Murphy, G.P., Beckley, S., Brady, M.F., Chu, T. M., deKernion, J.B., Dhabuwala, C., Gaeta, J F , Gibbons, R.P., Loening, S.A., McKiel, C.F., McLeod, D.G, Pontes, J.E., Prout, G.R., Scardino, P.T., Schlegel, J.U., Schmidt, J.D., Scott, W.W., Slack, N.H. and Soloway, M.S.: Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer, 51, 1264-1272, 1983.
13. Murphy, G.P., Huben, R P. and Priore, R.: Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer. Urology, 28, 36-40, 1986.
14. Huben, R.P., Murphy, G.P. and the investigators of the National Prostatic Cancer Project. A comparison of diethylstilbestrol or orchiectomy with buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostate. Cancer, 62, 1881-1887, 1988.
15. Slack, N.K., Mittelman, A., Brady, M.F., Murphy, G.P. and investigators in the National Prostatic Cancer Project. The importance of the stable category for chemotherapy treated patients with advanced and relapsing prostate cancer. Cancer, 46, 2393-2402, 1980.
16. Hickey, D., Cant, J. and Soloway, M.S.: Failure of chemotherapy to prolong life in patients with metastatic prostate cancer who have failed androgen deprivation. Urology, 31, 38-40, 1988.